Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult body.
A...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Autograft and Biologic Living Bone Reconstructions in Orthopaedic Oncology.

The Journal of the American Academy of Orthopaedic Surgeons·2025
Same author

Calcifying Pseudoneoplasm of the Neuraxis Involving the Posterior Skull Base: A Case Report and Literature Review.

International journal of surgical pathology·2021
Same author

Microvillus inclusion disease, a diagnosis to consider when abnormal stools and neurological impairments run together due to a rare syntaxin 3 gene mutation.

Journal of neonatal-perinatal medicine·2019
Same author

Impact of a Diabetes Risk Score on Lifestyle Education and Patient Adherence (IDEA) in Prediabetes: A Multisite Randomized Controlled Trial.

Military medicine·2015
Same author

In silico functional analyses and discovery of survival-associated microRNA signatures in pediatric osteosarcoma.

Oncoscience·2015
Same author

In vivo performance of combinations of autograft, demineralized bone matrix, and tricalcium phosphate in a rabbit femoral defect model.

Biomedical materials (Bristol, England)·2014

Related Experiment Video

Updated: Jul 10, 2026

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

Matrix metalloproteinase expression in high grade soft tissue sarcomas.

Stephanie H Alford1, Michael S Vrana, Lindsay Waite

  • 1Department of Orthopaedics, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229-3901, USA. alfords@uthscsa.edu

Oncology Reports
|November 6, 2007
PubMed
Summary

This study investigated matrix metalloproteinases (MMPs) and their inhibitors in high-grade soft tissue sarcomas. Researchers found no significant correlation between MMP expression levels and disease-free survival in these aggressive tumors.

More Related Videos

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
08:57

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Published on: May 17, 2024

Related Experiment Videos

Last Updated: Jul 10, 2026

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
08:57

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Published on: May 17, 2024

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Soft tissue sarcomas are a diverse group of mesenchymal tumors with unpredictable behavior.
  • Aggressive subtypes like malignant fibrous histiocytoma, synovial sarcoma, and liposarcoma pose significant clinical challenges.
  • Matrix metalloproteinases (MMPs) play crucial roles in tissue remodeling, and their dysregulation is implicated in cancer progression and metastasis.

Purpose of the Study:

  • To quantify the expression of specific matrix metalloproteinases (MMPs -1, -2, -8, -9, -13), extracellular matrix metalloproteinase inducer (EMMPRIN), and tissue inhibitors of metalloproteinases (TIMP-1, -2) in high-grade soft tissue sarcoma specimens.
  • To determine if there is a correlation between the expression levels of these molecules and disease-free survival in patients with high-grade soft tissue sarcomas.

Main Methods:

  • Real-time PCR was utilized to analyze the expression of MMPs, EMMPRIN, and TIMPs in 41 high-grade soft tissue sarcoma specimens.
  • The study included malignant fibrous histiocytomas, liposarcomas, and synovial sarcomas diagnosed between 1995 and 2003.
  • Statistical analysis was performed to assess the relationship between molecular expression and disease-free survival.

Main Results:

  • No significant differences in MMP expression were observed among the three studied high-grade soft tissue sarcoma subtypes.
  • The study found no statistically significant relationship between high or low levels of MMPs, EMMPRIN, or TIMPs and disease-free survival.
  • These findings align with existing research indicating variable correlations between MMP expression and outcomes in soft tissue sarcomas.

Conclusions:

  • The expression of MMPs, EMMPRIN, and TIMPs in high-grade soft tissue sarcomas does not appear to be a reliable predictor of disease-free survival.
  • Differences in the correlation between MMP expression and survival in carcinomas versus sarcomas may stem from the distinct cellular origins and biological characteristics of these tumor types.
  • Further research is warranted to elucidate the complex roles of these molecules in sarcoma pathogenesis and to identify potential therapeutic targets.